Idexx Laboratories | Kortsiktig Gjeld



Current Liabilities Endring Dato
Abbott USD 14.16B 745M 2024-12
Align Technology USD 2.04B 25.59M 2024-12
Dentsply International USD 1.59B 47M 2024-12
Dexcom USD 2.93B 1.2B 2024-12
Edwards Lifesciences USD 1.51B 438.9M 2024-12
Fujifilm JPY 1.15T 14.48B 2024-12
Globus Medical USD 855.91M 37.85M 2024-12
Henry Schein USD 2.8B 126M 2024-12
Hologic USD 1B 34.8M 2024-12
Idexx Laboratories USD 1.07B 58.69M 2024-12
Insulet USD 528.4M 22.2M 2024-12
Integra LifeSciences USD 922.13M 9.56M 2024-12
Intuitive Surgical USD 2.21B 536.8M 2024-12
Masimo USD 617.7M 19.9M 2024-12
Neogen USD 151.2M 28.51M 2024-11
Patterson Companies USD 1.31B 39.02M 2025-01
ResMed USD 851.96M 52.12M 2024-12
Roche Holding CHF 27.02B 424M 2024-12
Steris USD 891.12M 85.64M 2024-12
Tandem Diabetes Care USD 247.05M 12.23M 2024-12
Teleflex USD 649.36M 30.61M 2024-12
Thermo Fisher Scientific USD 13.33B 1.27B 2024-12
Zoetis USD 3.41B 1.71B 2024-12



Idexx Laboratories Kortsiktig Gjeld - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Mar 2025.